EKF
NEUTRALEKF Diagnostics Announces Share Buyback
The healthcare diagnostics company has announced a share buyback program.
EKF Diagnostics Holdings
22.70GBX
3.18%
Market Cap
102.41M
Volume
20.83k
4% of avg
P/E Ratio
0.16
EPS (TTM)
1.45
Beta
0.28
Day Range
21.20p - 22.70p
52 Week Range
18.40p22.70p33.80p
22.70p
Upcoming Events
20 May 2025
Annual General Meeting
EKF
NEUTRALEKF Diagnostics Announces Share Buyback
The healthcare diagnostics company has purchased 200,000 of its own shares at an average price of 21 pence per share.
EKF
NEUTRALEKF Diagnostics Publishes Annual Report and Notice of AGM
The healthcare diagnostics company has published its annual report and notice of upcoming AGM.
EKF
NEUTRALEKF Diagnostics Announces Share Buyback
The healthcare diagnostics company has purchased over 570,000 of its own shares as part of an ongoing buyback program.
EKF
NEUTRALEKF Diagnostics Directors Increase Shareholdings
The healthcare diagnostics company's directors have purchased additional shares in the business.
EKF
NEUTRALEKF Diagnostics Appoints New CEO
The healthcare diagnostics company has appointed a new Chief Executive Officer to lead the business.
EKF
NEUTRALEKF Diagnostics Announces Full Year Results and Investor Presentations
The global diagnostics company will announce its full year results and hold investor presentations on March 25, 2025.
EKF
NEUTRALEKF Diagnostics: Schroders Increases Stake to 5.0%
The medical device company has notified of a change in major shareholding, with Schroders PLC increasing its stake to over 5%.
EKF
NEUTRALEKF Diagnostics Announces Change in Major Shareholding
The healthcare company has announced a change in major shareholding, with Schroders PLC reducing its stake.